MAPK3 and breast carcinoma: In BT474 and MCF10A breast cancer cells transfected with the construct encoding HER2-T798M mutation, elevated HER2 kinase activity was detected and lapatinib did not block phosphorylation of HER2, EGFR3 or downstream Akt and ERK1/2.